| Primary |
| Product Used For Unknown Indication |
31.2% |
| Contraception |
25.8% |
| Menorrhagia |
15.1% |
| Menstrual Cycle Management |
4.3% |
| Menstruation Irregular |
3.2% |
| Endometriosis |
2.2% |
| Genital Haemorrhage |
2.2% |
| Menstrual Disorder |
2.2% |
| Oral Contraception |
2.2% |
| Bleeding Menstrual Heavy |
1.1% |
| Blood Pressure Fluctuation |
1.1% |
| Depression |
1.1% |
| Dysfunctional Uterine Bleeding |
1.1% |
| Dysmenorrhoea |
1.1% |
| Fibroids |
1.1% |
| Headache |
1.1% |
| Hormone Level Abnormal |
1.1% |
| Migraine |
1.1% |
| Muscle Spasms |
1.1% |
| Polycystic Ovaries |
1.1% |
|
| Metrorrhagia |
17.9% |
| Pregnancy On Oral Contraceptive |
10.5% |
| No Adverse Event |
8.4% |
| Vaginal Haemorrhage |
8.4% |
| Menstruation Delayed |
7.4% |
| Ovarian Cyst Ruptured |
5.3% |
| Amenorrhoea |
4.2% |
| Drug Dose Omission |
4.2% |
| Abdominal Pain |
3.2% |
| Chest Discomfort |
3.2% |
| Headache |
3.2% |
| Menstrual Disorder |
3.2% |
| Off Label Use |
3.2% |
| Rash |
3.2% |
| Vomiting |
3.2% |
| Withdrawal Bleed |
3.2% |
| Biliary Colic |
2.1% |
| Blood Pressure Increased |
2.1% |
| Cerebrovascular Accident |
2.1% |
| Extra Dose Administered |
2.1% |
|
| Secondary |
| Menorrhagia |
23.3% |
| Contraception |
20.0% |
| Dysfunctional Uterine Bleeding |
10.0% |
| Dysmenorrhoea |
10.0% |
| Menstrual Cycle Management |
6.7% |
| Bleeding Menstrual Heavy |
3.3% |
| Genital Haemorrhage |
3.3% |
| Headache |
3.3% |
| Hormone Level Abnormal |
3.3% |
| Menstrual Disorder |
3.3% |
| Migraine |
3.3% |
| Muscle Spasms |
3.3% |
| Product Used For Unknown Indication |
3.3% |
| Uterine Leiomyoma |
3.3% |
|
| Pulmonary Embolism |
28.6% |
| Menstruation Delayed |
14.3% |
| Adverse Drug Reaction |
7.1% |
| Menorrhagia |
7.1% |
| Metrorrhagia |
7.1% |
| Off Label Use |
7.1% |
| Pregnancy On Oral Contraceptive |
7.1% |
| Product Packaging Quantity Issue |
7.1% |
| Thrombosis |
7.1% |
| Uterine Leiomyoma |
7.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
44.0% |
| Contraception |
16.0% |
| Crohn's Disease |
8.0% |
| Depression |
8.0% |
| Pain |
8.0% |
| Blood Triglycerides Increased |
4.0% |
| Hypersensitivity |
4.0% |
| Low Density Lipoprotein Increased |
4.0% |
| Rheumatoid Arthritis |
4.0% |
|
| Insomnia |
33.3% |
| Cough |
16.7% |
| Nausea |
16.7% |
| Skin Burning Sensation |
16.7% |
| Therapeutic Response Decreased |
16.7% |
|
